Liste des spécialités Ordre … Liste des spécialités LS. 0000000016 00000 n L’OMS a élaboré une Liste modèle de médicaments essen-tiels, servant de base aux Etats membres pour la création de leur propre liste. Medicines under additional monitoring have a black inverted triangle displayed in their package leaflet and summary of product characteristics , together with a short sentence explaining what the … trailer All vaccines should comply with the WHO requirements for biological substances. Les questions à la conférencière peuvent être … Art der Veröffentlichung Dekret Erscheinungsdatum 01/01/2021. LEOs Zusatzinformationen: liste des médicaments admis - das Arzneimittelverzeichnis. 24571 0 obj<>stream Y N 02243683; … Medikamente und Wirkstoffe verständlich erklärt: Erfahren Sie mehr zu Nebenwirkungen, Dosierung und mehr! CONTEXTE DE L’ETUDE ET … liste des médicaments admis. Actuellement, plusieurs pays disposent d’une Liste Nationale de Médicaments Essentiels (LNME). 0000009253 00000 n Liste des médicaments concernés Voici la liste des médicaments qui ne devraient plus être pris en charge par la Sécurité sociale, selon Le Parisien du mardi 13 septembre. xref �� ���ˁ0]�[��`�B�}�\���\0+�u �p�� iHl�8��(�M����� endstream endobj 24570 0 obj<>/Size 24551/Type/XRef>>stream 2. Powder for dilution in 200 mL, 500 mL, 1 L: Oral > Other: ORS powder for dilution and zinc sulfate solid oral dosage form 20 mg (co-packaged), Oral > Liquid: 12 mg per mL powder for oral liquid, Oral > Solid: 30 mg capsule (as phosphate); 45 mg capsule (as phosphate); 75 mg capsule (as phosphate), Parenteral > General injections > IV: 50 mg in vial powder for injection; 100 mg in vial powder for injection; 50 mg per 10 mL in 10 mL vial; 100 mg per 20 mL in 20 mL vial; 200 mg per 40 mL in 40 mL vial, Parenteral > General injections > unspecified: 10 IU per mL, Oral > Solid: 500 mg tablet; 4 g granules in sachet, Parenteral > General injections > IV: 6 mg per mL. Short description: The eEML is a comprehensive, freely accessible, online database containing … kétamine Solution injectable: 50 mg (sous forme de chlorhydrate)/ml, en flacon de 10 ml. Spécialités et Génériques : Dentist/Dentiste: 85: Alberta Dental Association: AB: 95 College of Dental Surgeons of British Columbia; BC 07; Manitoba Dental Association MB ; 45 New Brunswick Dental Association; … Forumsdiskussionen, die den Suchbegriff enthalten; liste rouge - vor allem Liste der … 0000004102 00000 n NB Drug Plans Prescriber List/Liste des prescripteurs des régimes médicaments du N.-B. Liste de médicaments de premier recours . 1 EMA/52196/2015 Page 2/131 Member State Formulary A / Formulaire A Formulary B / Formulaire B Drug Name: Nom de Medicament: RAMQ ODB: 02243684; N; Y ZYVOXAM 600MG TABLET ZYVOXAM 600MG COMP. 0000000737 00000 n x�b```b``Kf`a``x��ǀ |@16 ������0�`d@�cg�$b7�c`U��*iF� LISTE DES FABRICANTS DE MÉDICAMENTS ET DES GROSSISTES EN MÉDICAMENTS Loi sur l'assurance médicaments - (L.R.Q., c. A-29.01, a.60) A) Fabricants reconnus par le ministre 3M Canada 3M Canada Inc. AA Pharma AA Pharma Inc. Abbott Laboratoires Abbott Ltée AbbVie La Corporation AbbVie Ab Diabete Abbott, Soins du diabète Laboratoires Abbott Accel Accel … Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors, Fixed-dose combinations of antiretrovirals, Ophthalmological preparations > Miotics and antiglaucoma medicines, Antidotes and other substances used in poisonings > Specific, Antimigraine medicines > For treatment of acute attack, Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs), Ophthalmological preparations > Anti-infective agents, Antidotes and other substances used in poisonings > Non-specific, Immunomodulators for non-malignant disease, Medicines for other common symptoms in palliative care, Antimalarial medicines > For curative treatment, Antimalarial medicines > For chemoprevention, Immunologicals > Sera and immunoglobulins, Muscle relaxants (peripherally-acting) and cholinesterase inhibitors, Ophthalmological preparations > Mydriatics, Preoperative medication and sedation for short-term procedures, Disease-modifying agents used in rheumatoid disorders (DMARDs), Recommendations for all immunization programmes, Antiasthmatic and medicines for chronic obstructive pulmonary disease, Dermatological medicines (topical) > Medicines affecting skin differentiation and proliferation, Dermatological medicines (topical) > Scabicides and pediculicides, Dermatological medicines (topical) > Anti-inflammatory and antipruritic medicines, Ophthalmological preparations > Anti-vascular endothelial growth factor (VEGF) preparations, Medicines administered to the neonate [c], Thyroid hormones and antithyroid medicines, Recommendations for some high-risk populations, Medicines used for obsessive compulsive disorders, Solutions correcting water, electrolyte and acid-base disturbances > Parenteral, Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations, Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations, Other medicines administered to the mother, Antiallergics and medicines used in anaphylaxis, Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors, Medicines for the treatment of 2nd stage African trypanosomiasis, Medicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors, Medicines for the treatment of 1st stage African trypanosomiasis, Adrenal hormones and synthetic substitutes, General anaesthetics and oxygen > Inhalational medicines, Recommendations for immunization programmes with certain characteristics, Medicines for prevention of HIV-related opportunistic infections, General anaesthetics and oxygen > Injectable medicines, Medicines for disorders due to psychoactive substance use, Dermatological medicines (topical) > Antifungal medicines, Dermatological medicines (topical) > Anti-infective medicines, Solutions correcting water, electrolyte and acid-base disturbances > Oral, Antischistosomals and other antitrematode medicines, Medicines for hepatitis C > Other antivirals for hepatitis C, Antipneumocystosis and antitoxoplasmosis medicines, Ophthalmological preparations > Anti-inflammatory agents, Ophthalmological preparations > Local anaesthetics, Solutions correcting water, electrolyte and acid-base disturbances > Miscellaneous. Liste des médicaments commercialisés - Triée par numéro national. Liste der Antigentests gem. 0000013095 00000 n Paper copies are not maintained. Respiratory > Inhalation > aerosol: 50 µg per dose (dipropionate); 250 µg per dose (dipropionatae), Parenteral > General injections > unspecified: 45 mg per 0.5 mL; 180 mg per 2 mL, Parenteral > General injections > IM: 900 mg in vial benzylpenicillin powder for injection (= 1.2 million IU); 1.44 g in vial benzylpenicillin powder for injection (= 2.4 million IU), Oral > Solid: 100 mg tablet; 50 mg tablet (scored); 12.5 mg tablet, Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt), Local > Topical > Cream: 0.1% (as valerate), Local > Topical > Ointment: 0.1% (as valerate), Parenteral > Locoregional injections > Intravitreal: 25 mg per mL, Parenteral > General injections > IV: 5 mg per mL in 1 mL ampoule (lactate), Oral > Solid: 2 mg tablet (hydrochloride), Parenteral > General injections > unspecified: 15 mg in vial (as sulfate), Parenteral > General injections > unspecified: 3.5 mg in vial powder for injection, Respiratory > Inhalation > aerosol: 100 µg per dose; 200 µg per dose, Respiratory > Inhalation > dry powder: 100 µg + 6 µg per dose; 200 µg + 6 µg per dose, Parenteral > Locoregional injections > Spinal anaesthesia: 0.5% in 4 mL ampoule (hydrochloride) + 7.5% glucose solution, Parenteral > General injections > unspecified: 0.25% in vial (hydrochloride); 0.5% in vial (hydrochloride), Parenteral > General injections > IV: 20 mg per mL (equivalent to 10 mg caffeine base per mL), Oral > Liquid: 20 mg per mL (equivalent to 10 mg caffeine base per mL), Oral > Solid: 15 mg tablet; 5 mg tablet; 25 mg tablet, Parenteral > General injections > unspecified: 3 mg per mL in 10 mL ampoule, Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule, Oral > Solid: 150 mg tablet; 500 mg tablet, Oral > Solid: 200 mg (scored); 100 mg (scored); 100 mg (chewable); 200 mg (chewable), Oral > Solid: 100 mg scored; 200 mg scored, Parenteral > General injections > IV: 100 µg per mL (heat stable), Parenteral > General injections > unspecified: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL, Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid, Parenteral > General injections > unspecified: 1 g in vial (as sodium salt) powder for injection, Oral > Liquid: 100 mg per 5 mL powder for oral liquid, Oral > Solid: 200 mg (as trihydrate); 400 mg (as trihydrate), Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt), Parenteral > General injections > unspecified: 250 mg in vial (as pentahydrate) powder for injection; 1 g in vial (as pentahydrate) powder for injection, Parenteral > General injections > IV: 2 g in vial + 0.5 g in vial powder for injection, Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt), Parenteral > General injections > IV: 250 mg in vial (as sodium salt) powder for injection; 750 mg in vial (as sodium salt) powder for injection; 1.5 g in vial (as sodium salt) powder for injection, Parenteral > General injections > IV: 1 g in vial powder for injection (sodium succinate), Parenteral > General injections > IM: 500 mg in 2 mL ampoule oily suspension for injection, Oral > Liquid: 150 mg per 5 mL (as palmitate), Local > Topical > Solution: 7.1% chlorhexidine digluconate (delivering 4% chlorhexidine), Local > Topical > Gel: 7.1% chlorhexidine digluconate (delivering 4% chlorhexidine), Local > Topical > Solution: 5% (digluconate) for dilution, Local > Topical > Powder: 0.1% available chlorine for solution, Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate), Oral > Solid: 150 mg tablet (as phosphate or sulfate); 100 mg tablet (as phosphate or sulfate), Oral > Solid: 150 mg tablet (as phosphate or sulfate), Oral > Solid: 100 mg tablet (as phosphate or sulfate); 150 mg tablet (as phosphate or sulfate), Oral > Liquid: 25 mg per 5 mL (hydrochloride), Oral > Solid: 100 mg (hydrochloride); 10 mg (hydrochloride); 25 mg (hydrochloride); 50 mg (hydrochloride), Parenteral > General injections > unspecified: 25 mg per mL in 2 mL ampoule (hydrochloride), Parenteral > General injections > IV: 50 mg per mL in 1 mL ampoule concentrate for injection, Local > Otological > drops: 0.3% (as hydrochloride), Parenteral > General injections > IV: 2 mg per mL (as hyclate), Oral > Liquid: 250 mg per 5 mL (anhydrous), Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL, Oral > Liquid: 125 mg per 5 mL powder for oral liquid; 250 mg per 5 mL powder for oral liquid, Parenteral > General injections > unspecified: 500 mg in vial powder for injection, Oral > Liquid: 75 mg per 5 mL (as palmitate hydrochloride), Oral > Solid: 150 mg (as hydrochloride) capsule, Parenteral > General injections > unspecified: 150 mg per mL (as phosphate) injection, Oral > Solid: 10 mg (hydrochloride); 25 mg (hydrochloride), Local > Topical > Other: 1% vaginal cream; 10% vaginal cream; 100 mg vaginal tablet; 500 mg vaginal tablet, Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid, Oral > Solid: 500 mg (as sodium salt) capsule; 1 g (as sodium salt) capsule, Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection, Oral > Solid: 25 mg; 50 mg; 100 mg; 200 mg, Parenteral > General injections > IV: 500 IU in vial powder for injection; 1000 IU in vial powder for injection, Parenteral > General injections > IV: 500 IU in vial powder for injection, Oral > Solid: 30 mg tablet (codeine phosphate), Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium), Parenteral > General injections > IV: injectable solution, Parenteral > General injections > unspecified: 50 mg per mL, Parenteral > General injections > IV: 500 mg in vial powder for injection, Oral > Solid: 25 mg tablet; 50 mg tablet, Parenteral > General injections > unspecified: 100 mg in vial powder for injection, Parenteral > General injections > IV: 100 mg in vial powder for injection, Oral > Solid: 30 mg tablet (as hydrochloride); 60 mg tablet (as hydrochloride), Parenteral > General injections > IV: 500 µg in vial powder for injection, Oral > Solid: 100 mg tablet; 50 mg tablet; 25 mg tablet, Oral > Solid: 75 mg; 400 mg; 600 mg; 800 mg, Oral > Solid: 20 mg tablet; 50 mg tablet; 70 mg tablet; 80 mg tablet; 100 mg tablet; 140 mg tablet, Parenteral > General injections > IV: 50 mg in vial (hydrochloride) powder for injection, Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate), Parenteral > General injections > IV: 4 µg per mL in 1 mL ampoule (acetate), Local > Nasal > Spray: 10 µg per dose (acetate), Parenteral > General injections > unspecified: 4 mg per mL (dexamethasone phosphate (as sodium)), Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule (as disodium phosophate salt), Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule (as disodium phosphate salt), Oral > Liquid: 0.5 mg per 5 mL; 2 mg per 5 mL, Oral > Solid: 0.5 mg; 0.75 mg; 1.5 mg; 4 mg, Parenteral > General injections > IV: 6% injectable solution, Local > Rectal > Gel: 5 mg per mL in 0.5 mL tubes; 5 mg per mL in 2 mL tubes; 5 mg per mL in 4 mL tubes, Local > Rectal > Solution: 5 mg per mL in 0.5 mL tubes; 5 mg per mL in 2 mL tubes; 5 mg per mL in 4 mL tubes, Oral > Solid: 5 mg (scored); 2 mg (scored), Local > Rectal > Solution: 2.5 mg; 5 mg; 10 mg, Parenteral > General injections > unspecified: 5 mg per mL, Oral > Solid: 50 mg tablet (dihydrogen citrate); 100 mg tablet (dihydrogen citrate), Parenteral > General injections > IV: 250 µg per mL in 2 mL ampoule, Oral > Solid: 40 mg + 320 mg tablet; 20 mg + 160 mg tablet, Parenteral > General injections > IM: 50 mg per mL in 2 mL ampoule, Parenteral > General injections > IM: 10000 IU in vial; 20000 IU in vial, Parenteral > General injections > IV: 20 mg per mL; 40 mg per mL, Oral > Liquid: 50 mg per 5 mL oral liquid, Oral > Solid: 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil), Parenteral > General injections > IV: 40 mg per mL in 5 mL vial (hydrochloride), Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride), Oral > Liquid: 25 mg per 5 mL (anhydrous); 50 mg per 5 mL (anhydrous), Oral > Solid: 50 mg (as hyclate); 100 mg (as hyclate), Oral > Solid: 100 mg (hydrochloride or hyclate), Oral > Solid: 100 mg (hydrochloride or hyclate); 100 mg dispersible tablet (as monohydrate), Oral > Solid: 600 mg tablet; 200 mg scored tablet, Oral > Solid: 600 mg + 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil), Oral > Solid: 400 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate, equivalent to 245 mg tenofovir disoproxil), Parenteral > General injections > IV: 200 mg per mL in 100 mL bottle (hydrochloride), Oral > Solid: 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil), Oral > Solid: 2.5 mg (as hydrogen maleate); 5 mg (as hydrogen maleate), Parenteral > General injections > SC: 20 mg per 0.2 mL in prefilled syringe; 40 mg per 0.4 mL in prefilled syringe; 60 mg per 0.6 mL in prefilled syringe; 80 mg per 0.8 mL in prefilled syringe; 100 mg per 1 mL in prefilled syringe; 120 mg per 0.8 mL in prefilled syringe; 150 mg per 1 mL in prefilled syringe; 150 mg per 1 mL in ampoule; 120 mg per 0.8 mL in ampoule; 20 mg per 0.2 mL in ampoule; 40 mg per 0.4 mL in ampoule; 60 mg per 0.6 mL in ampoule; 80 mg per 0.8 mL in ampoule; 100 mg per 1 mL in ampoule, Parenteral > General injections > SC: 20 mg per 0.2 mL in prefilled syringe; 40 mg per 0.4 mL in prefilled syringe; 60 mg per 0.6 mL in prefilled syringe; 80 mg per 0.8 mL in prefilled syringe; 100 mg per 1 mL in prefilled syringe; 120 mg per 0.8 mL in prefilled syringe; 150 mg per 1 mL in prefilled syringe; 150 mg per 1 mL in ampoule; 20 mg per 0.2 mL in ampoule; 40 mg per 0.4 mL in ampoule; 60 mg per 0.6 mL in ampoule; 80 mg per 0.8 mL in ampoule; 120 mg per 0.8 mL in ampoule; 100 mg per 1 mL in ampoule, Parenteral > Locoregional injections > Spinal anaesthesia: 30 mg per mL in 1 mL ampoule (ephedrine hydrochloride), Parenteral > General injections > IV: 100 µg per mL in 10 mL ampoule (as acid tartrate or hydrochloride), Local > Ophthalmological > Solution (eye drops): 2% (as hydrochloride), Parenteral > General injections > unspecified: 1 mg per mL in ampoule (as hydrochloride or hydrogen tartrate), Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule (as hydrochloride or hydrogen tartrate), Oral > Liquid: 250 µg per mL (10 000 IU per mL), Parenteral > General injections > unspecified: 200 µg in 1 mL ampoule (hydrogen maleate), Local > Ophthalmological > Ointment: 0.5%, Parenteral > General injections > unspecified: 1000 IU per 0.5 mL pre-filled syringe; 2000 IU per 0.5 mL pre-filled syringe; 3000 IU per 0.3 mL pre-filled syringe; 4000 IU per 0.4 mL pre-filled syringe; 5000 IU per 0.5 mL pre-filled syringe; 6000 IU per 0.6 mL pre-filled syringe; 8000 IU per 0.8 mL pre-filled syringe; 10000 IU per 1 mL pre-filled syringe; 20000 IU per 0.5 mL pre-filled syringe; 40000 IU per 1 mL pre-filled syringe, Parenteral > General injections > IM: 5 mg + 25 mg, Oral > Solid: 100 to 400 mg tablet (hydrochloride); 100 mg dispersible tablet, Oral > Solid: 275 mg + 75 mg + 400 mg + 150 mg tablet, Oral > Solid: 275 mg + 75 mg + 150 mg tablet, Local > Topical > Solution: 70% (denatured), Oral > Solid: 125 mg tablet; 250 mg tablet; 125 mg tablet (dispersible), Parenteral > General injections > IV: 20 mg per mL in 5 mL ampoule, Oral > Solid: 100 mg capsule; 50 mg capsule, Local > Topical > Transdermal patch: 12 µg/hour; 25 µg/hour; 50 µg/hour; 75 µg/hour; 100 µg/hour, Oral > Liquid: 25 mg per mL iron (as sulfate), Parenteral > General injections > SC: 120 µg per 0.2 mL in prefilled syringe; 300 µg per 0.5 mL in prefilled syringe; 480 µg per 0.8 mL in prefilled syringe; 300 µg per mL in 1 mL vial; 480 µg per 1.6 mL in 1.6 mL vial, Parenteral > General injections > IV: 2 mg per mL in vial, Parenteral > General injections > IV: 2.5 g per 250 mL infusion, Parenteral > General injections > IV: 50 mg in vial (fludarabine phosphate) powder for injection, Oral > Solid: 10 mg tablet (fludarabine phosphate), Local > Ophthalmological > Solution (eye drops): 1% (sodium salt), Parenteral > General injections > IV: 50 mg per mL in 5 mL ampoule, Parenteral > General injections > IM: 25 mg per mL in ampoule (decanoate); 25 mg per mL in ampoule (enanthate), Parenteral > General injections > IV: 5 mg per mL in 20 mL ampoule (sulfate); 1 g per mL in 1.5 mL ampoule (base), Parenteral > General injections > IV: 2 g in vial (as sodium) powder for injection; 4 g in vial (as sodium) powder for injection, Parenteral > General injections > IV: 10 mg per mL in 2 mL ampoule, Parenteral > General injections > IV: 200 mg in vial powder for injection; 1 g in vial powder for injection, Parenteral > General injections > unspecified: 10 mg per mL in 2 mL vial (as sulfate); 40 mg per mL in 2 mL vial (as sulfate), Local > Ophthalmological > Solution (eye drops): 0.3% (gentamicin sulfate), Oral > Solid: 30 mg controlled-release; 60 mg controlled-release; 80 mg controlled-release, Parenteral > General injections > unspecified: 1 mg per mL, Parenteral > General injections > IV: 5% isotonic; 10% hypertonic, Parenteral > General injections > IV: 50% hypertonic, Parenteral > General injections > IV: 4% + 0.18% (equivalent to Na+ 30 mmol/L and Cl- 30 mmol/L; 5% + 0.9% (equivalent to Na+ 150 mmol/L and Cl- 150 mmol/L); 5% + 0.45% (equivalent to Na+ 75 mmol/L and Cl- 75 mmol/L), Parenteral > General injections > IM: 5 mg per mL in ampoule, Parenteral > General injections > unspecified: 5 mg per mL in 1-mL ampoule, Parenteral > General injections > IV: 1000 IU per mL in 5 mL ampoule; 20000 IU per mL in 5 mL ampoule; 5000 IU per mL in 5 mL ampoule, Parenteral > General injections > IV: 20 mg in ampoule powder for injection (hydrochloride), Oral > Solid: 50 mg (hydrochloride); 25 mg (hydrochloride), Parenteral > General injections > unspecified: 100 mg in vial (as sodium succinate), Local > Rectal > Suppository: 25 mg (acetate), Parenteral > General injections > unspecified: 100 mg in vial powder for injection (as sodium succinate), Parenteral > General injections > IM: 1 mg per mL in 1 mL ampoule (as acetate); 1 mg per mL in 1 mL ampoule (as hydrochloride); 1 mg per mL in 1 mL ampoule (as sulfate), Oral > Solid: 200 mg; 250 mg; 300 mg; 400 mg; 500 mg; 1 g, Parenteral > General injections > unspecified: 20 mg per mL injection, Local > Topical > Transdermal patch: 1 mg per 72 hours transdermal patch, Parenteral > General injections > unspecified: 400 µg per mL injection; 600 µg per mL injection, Parenteral > General injections > IV: 5 mg per mL, Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection, Oral > Solid: 100 mg tablet; 400 mg tablet, Parenteral > General injections > SC: 40 IU per mL in 10 mL vial (soluble); 100 IU per mL in 10 mL vial (soluble), Parenteral > General injections > SC: 40 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin, Parenteral > General injections > IM: 0.5 mL (240 mg iodine) iodized oil in ampoule; 1 mL (480 mg iodine) iodized oil in ampoule, Oral > Liquid: 1 mL (480 mg iodine) iodized oil in ampoule; 0.5 mL (240 mg iodine) iodized oil in ampoule; 0.57 mL (308 mg iodine) iodized oil in dispenser bottle, Parenteral > General injections > unspecified: 140 to 350 mg iodine per mL in 5 mL ampoule; 140 to 350 mg iodine per mL in 10 mL ampoule; 140 to 350 mg iodine per mL in 20 mL ampoule, Respiratory > Inhalation > aerosol: 20 µg per dose, Parenteral > General injections > IV: 40 mg per 2 mL in 2 mL vial; 100 mg per 5 mL in 5 mL vial; 500 mg per 25 mL in 25 mL vial, Oral > Solid: 100 to 300 mg tablet; 50 mg tablet (scored); 100 mg tablet (dispersible), Oral > Solid: 50 mg + 150 mg + 75 mg tablet (dispersible); 75 mg + 400 mg + 150 mg tablet, Oral > Solid: 300 mg + 25 mg + 800 mg + 160 mg tablet (scored), Oral > Solid: 50 mg + 75 mg tablet (dispersible); 75 mg + 150 mg tablet; 150 mg + 300 mg tablet, Parenteral > General injections > unspecified: 50 mg per mL in 10 mL vial (as hydrochloride), Oral > Liquid: 3.1 to 3.7 g per 5 mL oral liquid, Oral > Solid: 30 mg + 50 mg + 60 mg Tablet; 150 mg + 200 mg + 300 mg Tablet, Oral > Solid: 30 mg + 60 mg Tablet; 150 mg + 300 mg Tablet, Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet; 200 mg tablet; 2 mg tablet (chewable, dispersible); 5 mg tablet (chewable, dispersible); 25 mg tablet (chewable, dispersible); 50 mg tablet (chewable, dispersible); 100 mg tablet (chewable, dispersible); 200 mg tablet (chewable, dispersible), Local > Ophthalmological > Solution (eye drops): 50 µg per mL eye drops, Parenteral > General injections > IM: 7.5 mg in prefilled syringe; 22.5 mg in prefilled syringe, Oral > Solid: 50 mg tablet; 150 mg tablet (as hydrochloride), Oral > Solid: 100 mg + 10 mg tablet; 250 mg + 25 mg tablet; 100 mg + 25 mg tablet, Oral > Solid: 250 mg tablet; 500 mg tablet; 750 mg tablet; 100 mg tablet (dispersible). 0000005185 00000 n Lorsque la présente liste limite la prescription de médicaments par la mention L, le médecin doit respecter cette limitation. Conférencière: Claire Hippert, Ph.D., Roche Innovation Center Basel. 0000006926 00000 n 0000003759 00000 n Consultez le règlement pour l'officine publique (PDF, versi Liste des médicaments commercialisés valable au 1er octobre 2020 Cette liste se base sur des données qui sont de la compétence de la Direction de la Santé, Division de la Pharmacie et des Médicaments, du Ministère de la sécurité sociale et de la Caisse nationale de santé. 0000010501 00000 n Last execution date: 13/01/2021 32 SOLIDAGO Prestat. April 2016 v.1 1 Prescriber ID Reference Code/Code de référence de l’ID du prescripteur Province. Liste des médicaments commercialisés - Triée par numéro national. Parenteral > Locoregional injections > Intradermal: Oral > Solid: 30 mg tablet (ulipristal acetate), Oral > Liquid: 50 mg per mL powder for oral solution, Oral > Liquid: 200 mg per 5 mL (sodium valproate), Oral > Solid: 200 mg (sodium valproate) enteric-coated tablet; 500 mg (sodium valproate) enteric-coated tablet; 100 mg (sodium valproate) crushable tablet, Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule (sodium valproate); 100 mg per mL in 10 mL ampoule (sodium valproate), Oral > Solid: 200 mg enteric-coated (sodium valproate); 500 mg enteric-coated (sodium valproate), Oral > Solid: 125 mg (as hydrochloride); 250 mg (as hydrochloride), Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection, Parenteral > General injections > IV: 10 mg in vial powder for injection (vecuronium bromide), Parenteral > General injections > IV: 2.5 mg per mL in 2 mL ampoule (hydrochloride), Oral > Solid: 40 mg (hydrochloride); 80 mg (hydrochloride), Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate), Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate), Parenteral > General injections > IV: 10 mg per mL in 1 mL vial; 50 mg per 5 mL in 5 mL vial, Parenteral > General injections > IV: 200 mg in vial powder for injection, Oral > Liquid: 40 mg per mL powder for oral liquid, Oral > Solid: 50 mg tablet; 200 mg tablet, Oral > Solid: 5 mg (sodium salt); 1 mg (sodium salt); 2 mg (sodium salt); 0.5 mg (sodium salt), Parenteral > General injections > unspecified: 2 mL ampoule; 5 mL ampoule; 10 mL ampoule, Local > Nasal > Spray: 0.05% w/v equivalent to 0.5 mg per mL, Parenteral > General injections > IV: 10 mg per mL in 20 mL vial solution for IV infusion injection, Oral > Solid: 250 mg capsule; 300 mg tablet, Parenteral > General injections > IV: 4 mg per 5 mL in 5 mL vial; 4 mg per 100 mL in 100 mL bottle.

Démontrer Que Les Conclusions De Pouchet Ne Sont Pas Correctes, Test Covid Boulogne-billancourt Dimanche, Roman Ado Humour, Bonne Journée Gif Animé, Lart Et La Beauté Citation, Château Des Enigmes Pons Tarif, Radiologie Cestas Téléphone, Bien Le Bonjour Gente Dame, Citation Faire Semblant D'aller Bien,